IL-1β can activate C/EBPβ, which, either alone or in synergy with NF-κB, upregulates the expression of factors such as tumor necrosis factor α (TNF-α), IL-1β, and IL-6, thereby exacerbating the inflammatory response in seropositive RA (69). This evidence concerns the gene TNF and rheumatoid arthritis.